Cough detection in cystic fibrosis, primary ciliary dyskinesia and health

Joerg Grosse-Onnebrink (Muenster, Germany), Joerg Grosse-Onnebrink, Andrea Radine, Claudius Werner, Heymut Omran

Source: International Congress 2016 – Non-inflammatory assessment of airway disorders
Session: Non-inflammatory assessment of airway disorders
Session type: Thematic Poster
Number: 1024
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Abstract

Objectives:In Cystic fibrosis (CF) and Primary ciliary dyskinesia (PCD) medical history of cough is important to identify disease progress, infective exacerbations and response to therapy. Thus treatment decisions are based on highly subjective patient´s reports what emphasises the need for objective cough monitoring.Methods:We investigated 28 healthy subjects (age 22.5 years (12; 43); median (min; max)), 21 patients with CF (26 (10; 44)) and 17 PCD patients (21 (9; 43)) at the University children´s hospital Muenster, Germany. In all patients cough-sounds were recorded and analysed with LEOSound-Monitor® (Heinen und Löwenstein, Bad Ems, Germany) during sleep. Kruskal-Wallis, Mann Whitney U test and Spearman´s correlation were applied.Results:The median (min; max) recorded time for healthy subjects, CF and PCD was 6.58 hours (5.42; 8.28), 7:58 (6:02; 9:46) and 7:51 (5:50; 9:34), respectively; cough counts per hour (cough/h median (min; max)) was 0 (0.0; 1.14), 2.15 (0.0; 62.6) and 0.37 (0.00; 7.75), respectively. Cough/h was statistically different between healthy subjects and CF (p<0.001) and between healthy subjects and PCD (p<0.01). CF patients tended to cough more than PCD patients (p=0.14). In CF cough/h correlates with FEV1%pred (p<0.001; rho=-0.81) and Immunoglobulin G (p=0.004; rho=0.65), in PCD cough/h correlates with FEV1%pred (p=0.02; rho=-0.64) and FVC%pred (p=0.03; rho=-0.60).Conclusions:Cough detection with LEOSound-Monitor® is feasible in CF, PCD and healthy subjects. CF and PCD patients cough significantly more than healthy subjects. Cough in CF and PCD correlates with parameters of disease severity, which indicates the usefulness of cough monitoring in CF and PCD.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Joerg Grosse-Onnebrink (Muenster, Germany), Joerg Grosse-Onnebrink, Andrea Radine, Claudius Werner, Heymut Omran. Cough detection in cystic fibrosis, primary ciliary dyskinesia and health. Eur Respir J 2016; 48: Suppl. 60, 1024

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Primary ciliary dyskinesia and non Cystic fibrosis bronchiectasis
Source: ERS Skills Course 2016
Year: 2016

Comparison of patient care pathway between primary ciliary dyskinesia and cystic fibrosis
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020


Lung function and nutritional status in children with cystic fibrosis and primary ciliary dyskinesia
Source: International Congress 2016 – Highlights in primary ciliary dyskinesia and asthma in childhood
Year: 2016

Ventilation inhomogeneity in children with cystic fibrosis and primary ciliary dyskinesia
Source: Annual Congress 2012 - New developments in paediatric respiratory physiology
Year: 2012


Chronic rhinosinusitis in non-cystic fibrosis bronchiectasis and primary ciliary dyskinesia
Source: Eur Respir Monogr 2017; 76: 148-161
Year: 2017


Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia
Source: Eur Respir J 2016; 47: 829-836
Year: 2016



Evidence for ciliary dyskinesia in cystic fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Comparison of bronchodilator responsiveness in children with primary ciliary dyskinesia and cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


Primary ciliary dyskinesia and mild cystic fibrosis: lung structure and function similarities.
Source: International Congress 2017 – Paediatric bronchology in clinical practice
Year: 2017

Functional dead space in children with cystic fibrosis or primary ciliary dyskinesia.
Source: International Congress 2018 – Assessing pathophysiology in children
Year: 2018

Assessment of mental health status in primary ciliary dyskinesia and cystic fibrosis patients and their parents
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Differences in airway inflammation between children with primary ciliary dyskinesia (PCD) and cystic fibrosis (CF)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Late presenting cystic fibrosis
Source: Annual Congress 2005 - Cystic fibrosis: no longer just kids‘ stuff
Year: 2005

Bacterial biofilms in bronchiectasis of primary ciliary dyskinesia (PCD) in comparison with cystic fibrosis (CF)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012

Is there a secondary defect in CFTR in the nasal epithelium of patients with primary ciliary dyskinesia?
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016


Diagnosing bronchiectasis and cystic fibrosis
Source: International Congress 2018 – ME8 Diagnosing bronchiectasis and cystic fibrosis
Year: 2018


Is cystic fibrosis the hemi-neglected part of respiratory medicine?
Source: Virtual Congress 2021 – CCC Thoracic oncology
Year: 2021


Early detection of pulmonary exacerbations in children with cystic fibrosis by electronic home monitoring of symptoms and lung function
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016


Neural respiratory drive and disease severity in cystic fibrosis
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009


The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021
Year: 2021